MULBERRY

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

ALXN1850OngoingActive not recruitingPhase 3Open NCT06079359 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…